Technology from IBBME Spin-off Receives 2nd Nod from FDA
Interface Biologics, Inc, the spin-off company begun by Professor Paul Santerre (IBBME), has received its second FDA clearance in less than a year for AngioDynamic’s BioFlo Port catheter. The